tradmap

EMN Financials Eastman Chemical Co

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 0.7% per year over the past 5 years.
  • Net income has grown slower than revenue (-0.2% vs 0.7% per year).
  • Free cash flow has declined 16.9% per year over the past 5 years.

Financial health

  • Total debt ($4.8B) exceeds cash ($566M); net debt is $4.2B.
  • Total debt has grown slower than revenue (-3.2% vs 0.7% per year).

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 80.4% of earnings and 89.9% of free cash flow.
  • The dividend has grown 1.3% per year over the past 5 years.
Revenue & net income
$0 $5B $11B 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 15% 30% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $540M $1B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $4B $8B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$4B -$726M $3B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $8.8B $474M 21.1% 0.0% $424M $4.8B $566M
2024 $9.4B $905M 24.4% 0.0% $688M $5.0B $837M
2023 $9.2B $894M 22.4% 0.0% $546M $4.8B $548M
2022 $10.6B $793M 20.2% 0.0% $364M $5.2B $493M
2021 $10.5B $857M 23.9% 0.0% $1.1B $5.2B $459M
2020 $8.5B $478M 23.3% 0.0% $1.1B $5.6B $564M
2019 $9.3B $759M 24.1% 0.0% $1.1B $5.8B $204M
2018 $10.2B $1.1B 24.4% 0.0% $1.0B $6.2B
2017 $9.5B $1.4B 24.7% 16.0% $1.0B $6.5B
2016 $9.0B $854M 26.2% 15.4% $759M $6.6B
2015 $9.6B $848M 26.7% 14.3% $972M $7.0B
2014 $9.5B $751M 23.3% 12.2% $840M $7.5B
2013 $9.3B $1.2B 29.7% 19.9% $814M $4.3B
2012 $8.1B $437M 21.7% 9.9% $663M $4.8B
2011 $7.2B $646M 21.9% 13.1% $168M $1.8B

Valuation over time

How the market has priced EMN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 9.2 18.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 0.7 1.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 2.8 5.6 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is EMN growing its revenue and profit?

Over the past 5 years, Eastman Chemical Co's revenue has grown 0.7% per year, and net income declined 0.2% per year. These are computed facts, not advice.

How much debt does EMN have?

As of FY2025, Eastman Chemical Co reported $4.8B of total debt against $566M of cash.

What is EMN's profit margin?

In FY2025, gross margin was 21.1%, operating margin —, and net margin 5.4%.

What is EMN's P/E ratio?

As of Jun '26, Eastman Chemical Co traded at a price-to-earnings ratio of about 17.0× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.